To help guide and insure the success of the ATP and its mission, three standing committees and other special committees have been constituted with expert, experienced advisors within many related scientific fields of interest.
ATP Executive Committee
was established to help guide the operations of the ATP and is comprised of key members of the scientific community and Autism Speaks scientific staff.
| Geraldine Dawson, PhD |
Chief Science Officer, Autism Speaks |
| Clara Lajonchere, PhD |
Vice President of Clinical Programs, Autism Speaks
|
| Sophia Colmarino, PhD |
Vice President of Research, Autism Speaks
|
| Daniel Lightfoot, PhD |
Director of Autism Tissue Program, Autism Speaks
|
| Jane Pickett, PhD |
Director of ATP Brain Resources and Data. Autism Speaks
|
| Simon Wallace, PhD |
Director of Scientific Development Europe, Autism Speaks
|
| Jenny Longmore, PhD |
Director of Research and Programs Europe, UK Brain Bank
|
| Keith Young, PhD |
Ass.Prof./Vice-Chair for Research, Psychiatry and Behavioral Science, Texas A&M
|
| Emanuel DiCicco-Bloom, MD |
Prof. Neuroscience/Cell Biology/Pediatrics NJ’s University Med. & Dentistry
|
| Timothy Neja, MS, MBA |
Vice President, Laboratory Operations, CryoLife, Inc. |
ATP Steering Committee
was established to help guide scientific strategy of the ATP and is comprised of active leaders in the scientific community, representing fields that are highly relevant to autism research such as nerodevelopmnental biology, neurology, neuroimaging, learning and cognition, immunology, genetics, biochemistry, and pharmacology.
| (Membership pending) |
Steering Committee Chair |
ATP Tissue Advisory Board
was established to help steward the donated tissue that has been entrusted to the ATP. This is an impartial, external review board that has been delegated the authority by Autism Speaks and the ATP to review the scientific merits of tissue applications, express its recommendations with respect to tissue applications, and advises on the optimal handling, processing and care of the ATP tissue collection. To avoid direct conflicts of interest, this board is comprised of active leaders with proven track records in the scientific community, representing fields which are highly relevant to autism research such as neuropathology, neuroscience, neuroimaging, brain banking, cell and molecular biology, and genetics, but are not actively conducting research in the field of autism.
| Keith A. Young, Ph.D. |
Tissue Advisory Board Chair
Associate Professor and Vice-Chair for Research, Psychiatry and Behavioral Science,
Texas A&M Health Science Center and Central Texas VA
|
| David S. Baskin, M.D., F.A.C.S. |
Professor Neurological Surgery and Residency Program Director, Director of Research,
Department of Neurosurgery at The Methodist Neurological Institute
|
| William M. Byne, M.D, Ph.D. |
Associate Professor, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY
|
| Emanuel DiCicco-Bloom, M.D. |
Professor of Neuroscience & Cell Biology, and also Professor of Pediatrics (Neurology)
NJ’s University of Medicine and Dentistry at Robert Wood Johnson Medical School
|
| Margaret M. Esiri, DM FRCPath |
Professor in Neuropathology, John Radcliffe Hospital, Oxford, London.
Director of the Thomas Willis Oxford Brain Collection
|
| Stephen D. Ginsberg, Ph.D. |
Associate Professor in Psychiatry & Neuroscience at the New York University School of Medicine
|
| Antonio Hardan, M.D. |
Assistant Professor of Psychiatry and Behavioral Sciences, Stanford University
|
| Christine M. Hulette, M.D. |
Professor of Pathology, Duke University Medical Center and
Director of the Kathleen Price Bryan brain bank
|
| Nicholas T. Lange, Sc.D. |
Associate Professor of Psychiatry at Harvard Medical School and of Biostatistics,
Harvard School of Public Health
|
| Deborah A. Lee, M.D., Ph.D. |
Global Medical Director-Neurology at Baxter Healthcare Corporation, Deerfield, IL
|
| Richard S. Nowakoski, Ph.D. |
Professor of Neuroscience and Cell Biology, New Jersey Professor of Spinal Cord Research,
UMDNJ-Robert Wood Johnson Medical School, New Jersey
|
ATP Special Advisory Committee
There are five associated special committees of the Tissue Advisory Board (TAB) assigned to specific interests of the ATP’s tissue handling and acquisition. These committees perform in-depth analysis with respect to their specified field of interest, help form strategic policies for the stewardship of the tissue, and assist in governing of the ATP’s tissue resources. These committees are subject to the ATP and report to the TAB.
- Tissue Processing and Distribution Committee
- Frozen Tissue and Genetic Resource Committee
- Stem Cell Committee
- Digital Imaging Committee
- Tissue Acquisition Committee
|
